Modiblast Pharma
modiblast.com
Health Care
Oncology Therapeutics
Biotechnology
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2020
Founded
Registers and programsofficial lists and records that name the company
| Legal entity | DSGVO Modiblast Pharma GmbH | its site |
| Registered | 24 Jan 2020 |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Cairn Therapeutics: Targeting the Cancer, just the cancer. Making cancer treatment simpler and safer with CT-262.
REGAINING CELL CYCLE CONTROL. Incyclix Bio is a next-generation cell cycle control company, advancing precision treatments that target the…
IDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells…
We relentlessly pursue every possibility to create new cancer breakthroughs and power our approach with people who think hard, care hard…
SirnaMed is committed to developing innovative therapies that directly target the cause of cancer development, progression and treatment…
Focused on oncology, we are committed to continuously innovating and developing new breakthrough cancer drugs, aiding cancer patients to…
Overview
Mission / Vision a new approach to treat blood cancers Reprogramming leukemic cells in vivo Modiblast is a privately held biopharmaceutical company developing proprietary cell reprogramming regimens aimed at turning cancer cells into antigen-presenting cells following the "Trojan horse" motif.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Oberhaching
Germany
HQ